Results 211 to 220 of about 561,728 (244)

LncRNA Airn preserves cardiomyocyte fatty acid oxidation to ameliorate diabetic cardiomyopathy by modulating the QKI-PPARα axis. [PDF]

open access: yesRedox Biol
Peng T   +11 more
europepmc   +1 more source

Diabetic cardiomyopathy

Revista Clínica Española (English Edition), 2022
The relationship between diabetes and heart failure is complex and bidirectional. Nevertheless, the existence of a cardiomyopathy attributable exclusively to diabetes has been and is still the subject of controversy, due, among other reasons, to a lack of a consensus definition.
A, Lorenzo-Almorós   +2 more
openaire   +3 more sources

CircRNAs in diabetic cardiomyopathy

Clinica Chimica Acta, 2021
Diabetic cardiomyopathy is an important irreversible chronic cardiovascular complication in diabetic patients. This condition is described as early diastolic dysfunction, myocardial fibrosis, cardiac hypertrophy, systolic dysfunction and other complex pathophysiological events, which ultimately lead to heart failure.
Hengquan Wan   +6 more
openaire   +2 more sources

Diabetic cardiomyopathy

American Heart Journal, 1989
Diabetes mellitus is associated with an excessive cardiovascular morbidity and mortality. Although one frequently associates cardiac dysfunction with enhanced coronary atherosclerosis in diabetic patients, evidence has accumulated for the existence of a specific "diabetic" cardiomyopathy.
S W, Zarich, R W, Nesto
openaire   +2 more sources

The diabetic cardiomyopathy

Acta Diabetologica, 2010
Diabetic cardiomyopathy has been defined as "a distinct entity characterized by the presence of abnormal myocardial performance or structure in the absence of epicardial coronary artery disease, hypertension, and significant valvular disease". The diagnosis stems from the detection of myocardial abnormalities and the exclusion of other contributory ...
TARQUINI, ROBERTO   +4 more
openaire   +3 more sources

Diabetic cardiomyopathy

Progress in Cardiovascular Diseases, 1985
Diabetic cardiomyopathy as a distinct entity was first recognized by Rubler et al. in diabetics with congestive heart failure (CHF), who had no evidence of coronary atherosclerosis. The Framingham study showed a 2.4-fold increased incidence of CHF in diabetic men and a 5.1-fold increase in diabetic women over 18 years.
F S, Fein, E H, Sonnenblick
openaire   +3 more sources

Diabetic Cardiomyopathy

Journal of Cardiac Failure, 2010
Individuals with diabetes are at a significantly greater risk of developing cardioymyopathy and heart failure despite adjusting for concomitant risks such as coronary artery disease or hypertension. This has led to the increased recognition of a distinct disease process termed as "diabetic cardiomyopathy." In this article, we perform an extensive ...
Shishir, Murarka, Mohammad Reza, Movahed
openaire   +2 more sources

Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy

open access: yesCirculation: Cardiovascular Imaging, 2011
Background-Metabolic and vascular disturbances contribute to diabetic cardiomyopathy, but the role of interstitial fibrosis in early disease is unproven.
Thomas Marwick   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy